VE-822,
VX-970,
VE-822,
1232416-25-9,
Berzosertib,
VX-970,
VE822,
VE 822,
UNII-L423PRV3V3,
L423PRV3V3,
5-(4-(isopropylsulfonyl)phenyl)-3-(3-(4-((methylamino)methyl)phenyl)isoxazol-5-yl)pyrazin-2-amine,
AK174892,
3-[3-[4-(methylaminomethyl)phenyl]-1,2-oxazol-5-yl]-5-(4-propan-2-ylsulfonylphenyl)pyrazin-2-amine,
2-Pyrazinamine, 3-(3-(4-((methylamino)methyl)phenyl)-5-isoxazolyl)-5-(4-((1-methylethyl)sulfonyl)phenyl)-,
2-Pyrazinamine, 3-[3-[4-[(methylamino)methyl]phenyl]-5-isoxazolyl]-5-[4-[(1-methylethyl)sulfonyl]phenyl]-,
3-[3-[4-[(Methylamino)methyl]phenyl]-5-isoxazolyl]-5-[4-[(1-methylethyl)sulfonyl]phenyl]-2-pyrazinamine,
Berzosertib [USAN],
Berzosertib (USAN/INN),
Berzosertib (VE-822),
AGN-PC-0CXKB3,
GTPL8003,
SCHEMBL3061890,
CHEMBL3989870,
EX-A529,
CHEBI:131166,
HMS3653C05,
VX970,
AOB87712,
BCP07948,
2789AH,
BDBM50226746,
MFCD27976794,
s7102,
ZINC96170459,
AKOS025404905,
CS-1861,
DB11794,
SB17265,
KS-00001D76,
NCGC00386313-07,
AS-17041,
BC600537,
DA-46989,
HY-13902,
QC-10953,
AB0098627,
FT-0700136,
SW220202-1,
A13289,
D11148,
3-(3-{4-[(METHYLAMINO)METHYL]PHENYL}-1,2-OXAZOL-5-YL)-5-[4-(PROPANE-2-SULFONYL)PHENYL]PYRAZIN-2-AMINE,
5-(4-isopropylsulfonylphenyl)-3-[3-[4-(methylaminomethyl)phenyl]isoxazol-5-yl]pyrazin-2-amine,
D0H6GI,
C24H25N5O3S,
ACN-029396,
B1383,
C000598331,
5-(4-(isopropylsulfonyl)phenyl)-3-(3-(4-((methylamino)methyl)phenyl)isoxazol-5-yl)pyrazin-2-amine(VE-822),